enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Roivant Sciences' lupus drug fails to reduce symptoms in mid ...

   www.aol.com/news/roivant-sciences-lupus-drug...

   The oral drug, brepocitinib, did not meet the primary study goal of reduction in disease activity at week 52 in patients of SLE, in which the immune system that normally helps protect the body ...

3. Belimumab - Wikipedia

   en.wikipedia.org/wiki/Belimumab

   Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. [8] Sales rose to $31.2 million in the first quarter of 2012. [37] The total cost for the first year of treatment with belimumab is $28,000. [38]

4. FDA approves new pain medication as an alternative to ... - AOL

   www.aol.com/fda-approves-pain-medication...

   The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. ... “Today’s approval is an important public health milestone in acute pain management ...

5. Drug-induced lupus erythematosus - Wikipedia

   en.wikipedia.org/wiki/Drug-induced_lupus_erythe...

   Furthermore, anti-histone antibodies can also be positive in drug-induced lupus. [citation needed] Anti-Histone antibodies are positive in up to 95% of patients with drug induced lupus. The most common medications associated with drug induced lupus are hydralazine, procainamide, isoniazid, methyldopa, chlorpromazine, quinidine, and minocycline. [9]

6. Betamethasone - Wikipedia

   en.wikipedia.org/wiki/Betamethasone

   Betamethasone is a steroid medication. [3] It is used for a number of diseases including rheumatic disorders such as rheumatoid arthritis and systemic lupus erythematosus, skin diseases such as dermatitis and psoriasis, allergic conditions such as asthma and angioedema, preterm labor to speed the development of the baby's lungs, Crohn's disease, cancers such as leukemia, and along with ...

7. FDA approves new type of non-opioid pain medication, 1st of ...

   www.aol.com/fda-approves-type-non-opioid...

   The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...

8. Daniel J. Wallace - Wikipedia

   en.wikipedia.org/wiki/Daniel_J._Wallace

   Daniel Jeffrey Wallace (born October 27, 1949) is an American rheumatologist, clinical professor, author, and fellow. [1] Wallace has published 500 peer reviewed publications, 9 textbooks, and 28 book chapters on topics such as lupus, Sjögren syndrome, osteoarthritis, and fibromyalgia. [2]

9. Lupus and other autoimmune diseases strike far more women ...

   www.aol.com/news/lupus-other-autoimmune-diseases...

   More than 24 million Americans, by some estimates up to 50 million, have an autoimmune disorder — diseases such as lupus, rheumatoid arthritis, multiple sclerosis and dozens more.